Skip to Content
Merck
  • HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells.

HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells.

European journal of immunology (2010-05-11)
Karlhans F Che, Rachel L Sabado, Esaki M Shankar, Veronica Tjomsland, Davorka Messmer, Nina Bhardwaj, Jeffrey D Lifson, Marie Larsson
ABSTRACT

Priming of T cells in lymphoid tissues of HIV-infected individuals occurs in the presence of HIV-1. DC in this milieu activate T cells and disseminate HIV-1 to newly activated T cells, the outcome of which may have serious implications in the development of optimal antiviral responses. We investigated the effects of HIV-1 on DC-naïve T-cell interactions using an allogeneic in vitro system. Our data demonstrate a dramatic decrease in the primary expansion of naïve T cells when cultured with HIV-1-exposed DC. CD4(+) and CD8(+) T cells showed enhanced expression of PD-1 and TRAIL, whereas CTLA-4 expression was observed on CD4(+) T cells. It is worth noting that T cells primed in the presence of HIV-1 suppressed priming of other naïve T cells in a contact-dependent manner. We identified PD-1, CTLA-4, and TRAIL pathways as responsible for this suppresion, as blocking these negative molecules restored T-cell proliferation to a higher degree. In conclusion, the presence of HIV-1 during DC priming produced cells with inhibitory effects on T-cell activation and proliferation, i.e. suppressor T cells, a mechanism that could contribute to the enhancement of HIV-1 pathogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,2′-Dithiodipyridine, ≥99.0% (GC)
Sigma-Aldrich
2,2′-Dithiodipyridine, powder
Sigma-Aldrich
Aldrithiol-2, 98%